Quotient Clinical

Abstract: Quotient Clinical is a drug development services provider, focused on helping clients reduce the time and cost of bringing a drug to market. We deliver integrated capabilities including formulation development, GMP drug product manufacturing and clinical pharmacology services to biotech and pharmaceutical clients globally.   We employ over 600 staff and operate from state-of-the-art manufacturing and clinical facilities in the UK and USA. We can support our clients by working under FDA or MHRA guidelines and offer a full range of support services, from study set-up right through to data analysis and reporting

Description: RapidFACT(R) accelerates the screening and optimisation of prototype formulations for all routes of delivery. In comparison to the conventional development of modified release (MR) dosage forms, RapidFACT can halve product development timelines, reduce consumption of drug substance by 85% and achieve cost efficiencies in excess of £500,000.
 
RapidFACT uses Quotient's unique Translational Pharmaceutics(R) platform, which integrates formulation development, real-time adaptive GMP manufacturing and clinical testing. Formulation compositions are adjusted in response to interim analysis of emerging clinical data allowing new compositions to be dosed every 7-14 days.

Category: Drug Product

Type: Small Molecules

Contact: Kieron Hall, VP BD EMEA ([email protected])

Back to all Posters